Vol 8, Supplement 5 (December 2019): Translational Andrology and Urology

Editorial Commentary

Enhanced power bacillus Calmette-Guérin—possibly too much of a good thing
Wojciech Krajewski, Sławomir Poletajew
Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer—an evaluation of radical cystectomy versus trimodal therapy costs
Diana E. Magee, Girish S. Kulkarni
PD-L1 testing in urothelial carcinoma: are we there yet?
Geert J. L. H. van Leenders
Enhancing response to immunotherapy in urothelial carcinoma by targeted inhibition of the histone methyltransferase G9a pathway
Denzel Zhu, Emily Barry, Alexander I. Sankin
Non-muscle invasive bladder cancer cystoscopic surveillance: from overuse to underuse and non-adherence impact
Leonardo O. Reis
Preservation of the bladder, but at what cost?
Niklas Harland, Arnulf Stenzl
Magnetic resonance imaging sequences for prostate cancer triage: two is a couple, three is a crowd?
Piet Dirix, Siska Van Bruwaene, Hendrik Vandeursen, Filip Deckers
Neoadjuvant chemotherapy in bladder cancer: not a matter on how much but on who it is effective
Giovanni Motterle, R. Jeffrey Karnes
Risk stratification system for biparametric prostate magnetic resonance imaging
Eugenio Martorana, Pietro Scialpi, Riccardo Grisanti, Michele Scialpi
A novel biparametric magnetic resonance imaging sequence provides a more efficient and similarly efficacious method of risk stratifying men clinically suspected of having prostate cancer
Megan Stout, Tasha Posid, Shawn Dason
Bladder cancer under staging: still unavoidable?
Angelo Naselli, Andrea Guarneri
Holding a MIRror up to the robustness of the prostate cancer urinary transcriptome
Adele E. Connor, Asia C. Jordan, Antoinette S. Perry
The inflammatory potential of diet and bladder cancer risk: results from a prospective cohort study
Christian Daniel Fankhauser, Hugh Mostafid
Challenges of urine-based molecular assays for the detection of urothelial cancer
Joep J. de Jong, Kim E. M. van Kessel, Monique J. Roobol, Joost L. Boormans
A new era in the detection of urothelial carcinoma by sequencing cell-free DNA
Yujiro Hayashi, Kazutoshi Fujita
Are we really seeking for equivalence?—The virtue of the robot is in technology
Aldo Brassetti, Riccardo Mastroianni, Giuseppe Simone
High-resolution microultrasound imaging for bladder cancer: the birth of a new diagnostic tool?
Marta Bottero, Emanuele Alì, Chiara Demofonti, Andrea Lancia, Riccardo Santoni, Cynthia Aristei, Gianluca Ingrosso
Patient decision aids for urinary diversion after radical cystectomy: their potential and pitfalls
Eva Browne, Jack Whooley, Jianwei Wang, Niall F. Davis
Urinary tract infection after radical cystectomy: a vexing problem despite prophylactic antibiotics
Joseph Y. Clark, Jay D. Raman
The challenge of matching assays to biology in DNA damage response biomarkers for response to radiotherapy in bladder cancer
Neil B. Desai, Aditya Bagrodia
Bacillus Calmette Guérin in bladder cancer: is more immune stimulation better?
Mar Valés-Gómez
Robotic assisted radical cystectomy: insights on long term oncological outcomes from the International Robotic Cystectomy Consortium
Maria Chiara Sighinolfi, Salvatore Micali, Ahmed Eissa, Stefano Carlo Maria Picozzi, Stefano Puliatti, Bernardo Rocco
Capturing recurrence in urothelial carcinoma: “more than meets the eye”
Aly-Khan A. Lalani, Sumanta K. Pal, Guru P. Sonpavde, Petros Grivas
Hypofractionation in prostate cancer radiotherapy: a step forward towards clinical routine
Barbara Vischioni, Rachele Petrucci, Francesca Valvo
The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer
Abhishek A. Solanki, Stanley L. Liauw
New metabolic tracers for detectable PSA levels in the post-prostatectomy setting: is the era of melting glaciers upcoming?
Rosario Mazzola, Francesco Cuccia, Vanessa Figlia, Niccolò Giaj-Levra, Luca Nicosia, Francesco Ricchetti, Michele Rigo, Nadia Pasinetti, Matteo Salgarello, Filippo Alongi
Commentary: underutilization of curative-intent therapy for patients with muscle-invasive bladder cancer in Sweden mimics the United States
Timothy N. Clinton, Michal Wiseman, Aleksandra Walasek, Eugene Pietzak
UroSEEK gene panel for bladder cancer surveillance
Regan Wong, Charles J. Rosser

Letter to the Editor

Influence of auriculotherapy on erectile dysfunction: commentaries and perspectives
Matias Noll, Carolina Rodrigues de Mendonça, Priscilla Rayanne e Silva Noll, Erika Aparecida Silveira